Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.
Chem Rev. 2021 Feb 24;121(4):2545-2647. doi: 10.1021/acs.chemrev.0c01122. Epub 2021 Feb 5.
Chem Rev. 2021.
PMID: 33543942
Free PMC article.
Review.
Toxic SOD1 trimers are off-pathway in the formation of amyloid-like fibrils in ALS.
Hnath B, Dokholyan NV.
Hnath B, et al.
Biophys J. 2022 Jun 7;121(11):2084-2095. doi: 10.1016/j.bpj.2022.04.037. Epub 2022 May 3.
Biophys J. 2022.
PMID: 35505609
Free PMC article.
Item in Clipboard
A Piecewise Design Approach to Engineering a Miniature ACE2 Mimic to Bind SARS-CoV-2.
Vishweshwaraiah YL, Hnath B, Wang J, Chandler M, Mukherjee A, Yennawar NH, Booker SJ, Afonin KA, Dokholyan NV.
Vishweshwaraiah YL, et al. Among authors: hnath b.
ACS Appl Bio Mater. 2024 May 3. doi: 10.1021/acsabm.4c00222. Online ahead of print.
ACS Appl Bio Mater. 2024.
PMID: 38700999
Item in Clipboard
Big versus small: The impact of aggregate size in disease.
Hnath B, Chen J, Reynolds J, Choi E, Wang J, Zhang D, Sha CM, Dokholyan NV.
Hnath B, et al.
Protein Sci. 2023 Jul;32(7):e4686. doi: 10.1002/pro.4686.
Protein Sci. 2023.
PMID: 37243896
Free PMC article.
Review.
Item in Clipboard
Adaptation-proof SARS-CoV-2 vaccine design.
Vishweshwaraiah YL, Hnath B, Rackley B, Wang J, Gontu A, Chandler M, Afonin KA, Kuchipudi SV, Christensen N, Yennawar NH, Dokholyan NV.
Vishweshwaraiah YL, et al. Among authors: hnath b.
Adv Funct Mater. 2022 Dec 2;32(49):2206055. doi: 10.1002/adfm.202206055. Epub 2022 Oct 3.
Adv Funct Mater. 2022.
PMID: 36590650
Free PMC article.
Item in Clipboard
Adaptation-proof SARS-CoV-2 vaccine design.
Vishweshwaraiah YL, Hnath B, Rackley B, Wang J, Gontu A, Chandler M, Afonin KA, Kuchipudi SV, Christensen N, Yennawar NH, Dokholyan NV.
Vishweshwaraiah YL, et al. Among authors: hnath b.
bioRxiv [Preprint]. 2022 May 18:2022.05.17.492310. doi: 10.1101/2022.05.17.492310.
bioRxiv. 2022.
PMID: 35611332
Free PMC article.
Updated.
Preprint.
Item in Clipboard
Cite
Cite